围孕产期甲状腺疾病相关诊疗指南的解读

doi:10.12280/gjfckx.20230486

摘要/Abstract

摘要：

正常的甲状腺功能对围产期母体和胎儿的健康尤为重要。越来越多的研究发现，甲状腺疾病可能会导致女性不孕，增加妊娠期高血压、甲状腺危象、自然流产、早产和死产等妊娠相关并发症，并可能损害后代的神经智力发育。妊娠期甲状腺发生特有的生理性变化，使妊娠期甲状腺疾病的诊断标准有别于非妊娠妇女，且此疾病的症状、体征常与妊娠期的生理性表现重叠，增加了临床诊断的难度。甲状腺疾病是围孕产期常见的内分泌疾病，其病情复杂、诊疗策略需兼顾母婴安全，国内外专业学会相继发布了相关的更新指南，对该疾病临床管理中的具体问题给出了详细建议。结合目前最新的研究证据，对国内外新近指南中的诊治要点进行对比分析及解读，为临床医生对围孕产期甲状腺疾病的诊治提供参考。

关键词: 围产期, 孕妇, 甲状腺疾病, 诊疗指南, 妊娠结局

Abstract:

In the peripartum period, euthyroidism is essential for maternal-fetal health. More and more studies have found that thyroid diseases may lead to female infertility, increase the risk of pregnancy-related complications such as gestational hypertension, thyroid crisis, spontaneous abortion, preterm birth, and stillbirth, and may impair the neurological and intellectual development of offspring. The diagnostic criteria of thyroid diseases during pregnancy are different from those of non-pregnant women due to the unique physiological changes of thyroid in this special period. Moreover, the symptoms and signs of perinatal thyroid diseases often overlap with the physiological manifestations of pregnancy, which increases the difficulty of clinical diagnosis. Thyroid diseases are common endocrine disease in the peripartum period, and its situation is complex, its diagnostic and treatment strategies should consider the safety of both mothers and infants. Relevant updated guidelines have been issued by domestic and foreign professional societies, which provided detailed suggestions regarding clinical managements of thyroid diseases during peripartum period. This review combined with the latest research evidence comparatively analyzes and interprets the main points of diagnosis and treatment of the recent guidelines at home and abroad, in order to provide references for clinicians regarding the diagnosis and treatment of perinatal thyroid diseases.

Key words: Peripartum period, Pregnant women, Thyroid diseases, Diagnostic and treatment guideline, Pregnancy outcome

覃苑, 李冰川. 围孕产期甲状腺疾病相关诊疗指南的解读[J]. 国际妇产科学杂志, 2023, 50(6): 673-678.

QIN Yuan, LI Bing-chuan. Interpretation of Related Guidelines for Diagnosis and Treatment of Thyroid Diseases During Preconceptional and Perinatal Period[J]. Journal of International Obstetrics and Gynecology, 2023, 50(6): 673-678.

参考文献 40

[1]	Li Y, Shan Z, Teng W, et al. The Iodine Status and Prevalence of Thyroid Disorders Among Women of Childbearing Age in China: National Cross-sectional Study[J]. Endocr Pract, 2021, 27(10):1028-1033. doi: 10.1016/j.eprac.2021.03.017.
[2]	Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid, 2011, 21(10):1081-1125. doi: 10.1089/thy.2011.0087. pmid: 21787128
[3]	Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?[J]. J Clin Endocrinol Metab, 2014, 99(1):73-79. doi: 10.1210/jc.2013-1674. pmid: 24276458
[4]	Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum[J]. Thyroid,2017, 27(3):315-389. doi: 10.1089/thy.2016.0457.
[5]	Gao X, Li Y, Li J, et al. Gestational TSH and FT4 Reference Intervals in Chinese Women: A Systematic Review and Meta-Analysis[J]. Front Endocrinol(Lausanne), 2018, 9:432. doi: 10.3389/fendo.2018.00432.
[6]	《妊娠和产后甲状腺疾病诊治指南》第2版编撰委员会,中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南(第2版)[J]. 中华内分泌代谢杂志, 2019, 35(8):636-665. doi:10.3760/cma.1000-6699.2019.08.003.
[7]	Knøsgaard L, Andersen S, Hansen AB, et al. Maternal hypothyroidism and adverse outcomes of pregnancy[J]. Clin Endocrinol(Oxf), 2023, 98(5):719-729. doi: 10.1111/cen.14853.
[8]	Derakhshan A, Peeters RP, Taylor PN, et al. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis[J]. Lancet Diabetes Endocrinol, 2020, 8(6):501-510. doi: 10.1016/S2213-8587(20)30061-9.
[9]	Jansen TA, Korevaar T, Mulder TA, et al. Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort[J]. Lancet Diabetes Endocrinol, 2019, 7(8):629-637. doi: 10.1016/S2213-8587(19)30153-6.
[10]	Thyroid Disease in Pregnancy: ACOG Practice Bulletin Summary, Number 223[J]. Obstet Gynecol, 2020, 135(6):1496-1499. doi: 10.1097/AOG.0000000000003894. pmid: 32443078
[11]	Zhu P, Chu R, Pan S, et al. Impact of TPOAb-negative maternal subclinical hypothyroidism in early pregnancy on adverse pregnancy outcomes[J]. Ther Adv Endocrinol Metab, 2021, 12: 20420188211054690. doi: 10.1177/20420188211054690.
[12]	Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, et al. Recurrent miscarriage: evidence to accelerate action[J]. Lancet, 2021, 397(10285):1675-1682. doi: 10.1016/S0140-6736(21)00681-4. pmid: 33915096
[13]	Gietka-Czernel M, Glinicki P. Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment[J]. Pol Arch Intern Med, 2021, 131(3):266-275. doi: 10.20452/pamw.15626.
[14]	Luo J, Yuan J. Effects of Levothyroxine Therapy on Pregnancy and Neonatal Outcomes in Subclinical Hypothyroidism[J]. Int J Gen Med, 2022, 15:6811-6820. doi: 10.2147/IJGM.S366981. pmid: 36051566
[15]	Etemadi A, Amouzegar A, Mehran L, et al. Isolated Hypothyroxinemia in Iranian Pregnant Women, the Role of Iodine Deficiency: A Population-Based Cross-Sectional Study[J]. Thyroid, 2020, 30(2):262-269. doi: 10.1089/thy.2019.0047. pmid: 31724489
[16]	Moreno-Reyes R, Corvilain B, Daelemans C, et al. Iron Deficiency Is a Risk Factor for Thyroid Dysfunction During Pregnancy: A Population-Based Study in Belgium[J]. Thyroid, 2021, 31(12):1868-1877. doi: 10.1089/thy.2021.0286. pmid: 34538131
[17]	Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar T, Derakhshan A, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis[J]. JAMA, 2019, 322(7):632-641. doi: 10.1001/jama.2019.10931. pmid: 31429897
[18]	Xu Y, Chen H, Ren M, et al. Thyroid autoimmunity and adverse pregnancy outcomes: A multiple center retrospective study[J]. Front Endocrinol(Lausanne), 2023, 14:1081851. doi: 10.3389/fendo.2023.1081851.
[19]	Chen J, Jiao XF, Zhang L, et al. The impact of levothyroxine therapy on pregnancy and neonatal outcomes in euthyroid pregnant women with thyroid autoimmunity: A systematic review, meta-analysis and trial sequential analysis[J]. Front Pharmacol, 2023, 14:1054935. doi: 10.3389/fphar.2023.1054935.
[20]	《孕产期甲状腺疾病防治管理指南》编撰委员会,中华医学会内分泌学分会,中华预防医学会妇女保健分会. 孕产期甲状腺疾病防治管理指南[J]. 中国妇幼卫生杂志, 2022, 13(4):1-15. doi: 10.19757/j.cnki.issn1674-7763.2022.04.001.
[21]	Dong AC, Stagnaro-Green A. Differences in Diagnostic Criteria Mask the True Prevalence of Thyroid Disease in Pregnancy: A Systematic Review and Meta-Analysis[J]. Thyroid, 2019, 29(2):278-289. doi: 10.1089/thy.2018.0475. pmid: 30444186
[22]	Guo N, Xue M, Liang Z. Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves′ disease[J]. Arch Gynecol Obstet, 2023, 308(2):403-411. doi: 10.1007/s00404-022-06774-z.
[23]	Nazarpour S, Amiri M, Bidhendi Yarandi R, et al. Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies[J]. Int J Endocrinol Metab, 2022, 20(3):e120949. doi: 10.5812/ijem-120949.
[24]	Liu Y, Li Q, Xu Y, et al. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis[J]. PLoS One, 2023, 18(5):e0286097. doi: 10.1371/journal.pone.0286097.
[25]	Turunen S, Vääräsmäki M, Lahesmaa-Korpinen AM, et al. Maternal hyperthyroidism and pregnancy outcomes: A population-based cohort study[J]. Clin Endocrinol(Oxf), 2020, 93(6):721-728. doi: 10.1111/cen.14282.
[26]	Pearce EN. Management of thyrotoxicosis: preconception, pregnancy, and the postpartum period[J]. Endocr Pract, 2019, 25(1):62-68. doi: 10.4158/EP-2018-0356. pmid: 30289300
[27]	Hamidi OP, Barbour LA. Endocrine Emergencies During Pregnancy: Diabetic Ketoacidosis and Thyroid Storm[J]. Obstet Gynecol Clin North Am, 2022, 49(3):473-489. doi: 10.1016/j.ogc.2022.02.003.
[28]	Smith LH, Danielsen B, Allen ME, et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry[J]. Am J Obstet Gynecol, 2003, 189(4):1128-1135. doi: 10.1067/s0002-9378(03)00537-4. pmid: 14586366
[29]	Nobre GM, Tramontin MY, Treistman N, et al. Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer[J]. Arch Endocrinol Metab, 2021, 65(6):768-777. doi: 10.20945/2359-3997000000413.
[30]	Kitahara CM, Slettebø Daltveit D, Ekbom A, et al. Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry Study[J]. Am J Epidemiol, 2023, 192(1):70-83. doi: 10.1093/aje/kwac163.
[31]	Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development[J]. J Clin Endocrinol Metab, 2002, 87(4):1768-1777. doi: 10.1210/jcem.87.4.8434.
[32]	Visser WE, van den Berg SAA, et al. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer[J]. Thyroid, 2020, 30(4):580-587. doi: 10.1089/thy.2019.0504. pmid: 31928168
[33]	Poppe K, Bisschop P, Fugazzola L, et al. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction[J]. Eur Thyroid J,2021, 9(6):281-295. doi: 10.1159/000512790.
[34]	Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period[J]. Nat Rev Endocrinol, 2022, 18(3):158-171. doi: 10.1038/s41574-021-00604-z. pmid: 34983968
[35]	Tuzil J, Bartakova J, Watt T, et al. Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies[J]. Expert Rev Pharmacoecon Outcomes Res, 2021, 21(6):1179-1193. doi: 10.1080/14737167.2021.1941882.
[36]	Rahnama R, Mahmoudi AR, Kazemnejad S, et al. Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies[J]. Clin Exp Med, 2021, 21(1):79-88. doi: 10.1007/s10238-020-00663-y.
[37]	Du YJ, Xin X, Cui N, et al. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women[J]. Eur J Obstet Gynecol Reprod Biol, 2019, 234:207-212. doi: 10.1016/j.ejogrb.2019.01.025.
[38]	Bucci I, Giuliani C, Di Dalmazi G, et al. Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome[J]. Front Endocrinol(Lausanne), 2022, 13:768363. doi: 10.3389/fendo.2022.768363.
[39]	Kuroda M, Kuroda K, Segawa T, et al. Levothyroxine supplementation improves serum anti-Müllerian hormone levels in infertile patients with Hashimoto′s thyroiditis[J]. J Obstet Gynaecol Res, 2018, 44(4):739-746. doi: 10.1111/jog.13554.
[40]	Poppe K, Autin C, Veltri F, et al. Thyroid autoimmunity and intracytoplasmic sperm injection outcome: a systematic review and meta-analysis[J]. J Clin Endocrinol Metab,2018 Mar 12. doi: 10.1210/jc.2017-02633.